- abrocitinibPhase-3-Katalysator (PFE)
- acasunlimabPhase-3-Katalysator (GMAB)
- alectinibPhase-2/3-Katalysator (NUVL)
- anifrolumabPhase-3-Katalysator (AZN)
- axitinibPhase-3-Katalysator (PFE)
- belzutifanPhase-3-Katalysator (MRK)
- binimetinibPhase-3-Katalysator (PFE)
- cagrilintidePhase-3-Katalysator (NVO)
- camizestrantPhase-3-Katalysator (AZN)
- cenerimodPhase-3-Katalysator (VTRS)
- cretostimogene grenadenorepvecPhase-3-Katalysator
- dapagliflozinPhase-3-Katalysator (AZN)
- darolutamidePhase-3-Katalysator (AZN)
- darovasertibPhase-2/3-Katalysator (IDYA)
- datopotamab deruxtecanPhase-3-Katalysator (AZN)
- daunorubicinPhase-2/3-Katalysator (KURA)
- deucravacitinibPhase-3-Katalysator (BMY)
- deucrictibantPhase-3-Katalysator (PHVS)
- deuruxolitinibPhase-2/3-Katalysator (TEVA)
- disitamab vedotinPhase-3-Katalysator (PFE)
- donidalorsenPhase-3-Katalysator (IONS)
- efgartigimodPhase-2/3-Katalysator (ARGX)
- eftilagimod alfaPhase-3-Katalysator (IMMP)
- eftilagimod alphaPhase-2/3-Katalysator (IMMP)
- elranatamabPhase-3-Katalysator (PFE)
- encorafenibPhase-3-Katalysator (PFE)
- enlicitide decanoatePhase-3-Katalysator (MRK)
- epcoritamabPhase-3-Katalysator (GMAB)
- erwinia asparaginasePhase-2/3-Katalysator (DAN)
- fianlimabPhase-3-Katalysator (REGN)
- golcadomidePhase-3-Katalysator (BMY)
- ianalumabPhase-3-Katalysator (NVS)
- ibrutinibPhase-3-Katalysator (MRK)
- ifinatamab deruxtecanPhase-3-Katalysator (MRK)
- inclisiranPhase-3-Katalysator (NVS)
- iptacopanPhase-3-Katalysator (NVS)
- ivonescimabPhase-3-Katalysator (SMMT)
- laroprovstatPhase-3-Katalysator (AZN)
- lebrikizumabPhase-3-Katalysator (LLY)
- lerotinibPhase-3-Katalysator (SBFM)
- lisaftoclaxPhase-3-Katalysator (AAPG)
- litifilimabPhase-3-Katalysator (BIIB)
- lorlatanibPhase-3-Katalysator (PFE)
- lutikizumabPhase-3-Katalysator (ABBV)
- maridebart cafraglutidePhase-3-Katalysator (AMGN)
- mercaptopurinePhase-2/3-Katalysator (DAN)
- mevrometostatPhase-3-Katalysator (PFE)
- mezigdomidePhase-3-Katalysator (BMY)
- mibavademabPhase-3-Katalysator (REGN)
- midazolamPhase-3-Katalysator (COGT)
- migalastatPhase-3-Katalysator (SNY)
- minoxidilPhase-3-Katalysator (SBFM)
- monalizumabPhase-3-Katalysator (AZN)
- nelarabinePhase-2/3-Katalysator (DAN)
- nemtabrutinibPhase-3-Katalysator (MRK)
- niraparibPhase-2/3-Katalysator (IMNN)
- obicetrapibPhase-3-Katalysator (NAMS)
- oleclumabPhase-3-Katalysator (AZN)
- olezarsenPhase-3-Katalysator (IONS)
- olverembatinibPhase-3-Katalysator (AAPG)
- olvimulogene nanivacirepvecPhase-3-Katalysator (GNLX)
- orforglipronPhase-3-Katalysator (LLY)
- paltusotinePhase-3-Katalysator (CRNX)
- patidegibPhase-3-Katalysator (SLGL)
- pazopanibPhase-3-Katalysator (INTS)
- pegaspargasePhase-2/3-Katalysator (DAN)
- pelabresibPhase-3-Katalysator (NVS)
- pitolisantPhase-3-Katalysator (HRMY)
- povorcitinibPhase-3-Katalysator (INCY)
- ralinepagPhase-3-Katalysator (UTHR)
- ravulizumabPhase-3-Katalysator (AZN)
- recombinant human tissue kallikreinKatalysator
- rescue medicationsPhase-3-Katalysator (MRK)
- resmetiromPhase-3-Katalysator (MDGL)
- retatrutidePhase-3-Katalysator (LLY)
- rezvilutamidePhase-3-Katalysator (AZN)
- rilvegostomigPhase-3-Katalysator (AZN)
- rinaPhase-3-Katalysator (GMAB)
- ritlecitinibPhase-3-Katalysator (PFE)
- ritlecitinib higherPhase-3-Katalysator (PFE)
- ritlecitinib lowerPhase-3-Katalysator (PFE)
- rosuvastatin calciumPhase-3-Katalysator (MRK)
- sacituzumab govitecan hziyPhase-3-Katalysator (GILD)
- setmelanotidePhase-3-Katalysator (RYTM)
- sonelokimabPhase-3-Katalysator (MLTX)
- sotagliflozinPhase-3-Katalysator (LXRX)
- sotorasibPhase-3-Katalysator (AMGN)
- supportive care measuresPhase-3-Katalysator (MRK)
- tafasitamabPhase-3-Katalysator (INCY)
- talazoparibPhase-3-Katalysator (PFE)
- tapinarofPhase-3-Katalysator (OGN)
- tarlatamabPhase-3-Katalysator (AMGN)
- telisotuzumab adizutecanPhase-3-Katalysator (ABBV)
- telitaciceptPhase-3-Katalysator (VOR)
- tezepelumabPhase-3-Katalysator (AZN)
- tirzepatidePhase-3-Katalysator (LLY)
- tisagenlecleucelPhase-3-Katalysator (NVS)
- tocilizumabPhase-3-Katalysator (MRK)
- tofacitinibPhase-3-Katalysator (PFE)
- tradipitantPhase-3-Katalysator (VNDA)
- tulisokibartPhase-3-Katalysator (MRK)
- utomilumabPhase-3-Katalysator (PFE)
- vepdegestrantPhase-3-Katalysator (PFE)
- zanidatamabPhase-3-Katalysator (JAZZ)
- zanubrutinibPhase-3-Katalysator (ONC)
- zasocitinibPhase-3-Katalysator (TAK)
- ziltivekimabPhase-3-Katalysator (NVO)
- zodasiranPhase-3-Katalysator (ARWR)
Informative Daten aus öffentlichen Studienregistern. Keine Anlageberatung.